|本期目录/Table of Contents|

[1]邵峻,张文静,游雅婷,等.肺肉瘤样癌伴EML4-ALK融合一例[J].中华肺部疾病杂志,2021,(03):403-404.[doi:10.3877/cma.j.issn.1674-6902.2021.03.041]
点击复制

肺肉瘤样癌伴EML4-ALK融合一例(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2021年03期
页码:
403-404
栏目:
病例报告
出版日期:
2021-06-20

文章信息/Info

Title:
-
作者:
邵峻1张文静2游雅婷2陈旻旻2陈景昭2何荣玲2白莉2
5222403 合江,四川泸州合江县人民医院内科二病区1 400037 重庆,陆军(第三)军医大学第二附属医院呼吸与危重症医学科2
Author(s):
-
关键词:
肺肉瘤样癌 EML4-ALK 诊断治疗 融合
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2021.03.041
摘要:
-
Abstract:
-

参考文献/References:

1 Shum E, Stuart M, Borczuk A, et al. Recent advances in the management of pulmonary sarcomatoid carcinoma[J]. Expert Rev Respir Med, 2016, 10(4): 407-416.
2 Lococo F, Gandolfi G, Rossi G, et al. Deep sequencing analysis reveals that KRAS nutation is a marker of poor prognosis in patients with pulmonary sarcomatoid carcinoma[J]. J Thorac Oncol, 2016, 11(8): 1282-1292.
3 Fallet V, Saffroy R, Girard N, et al. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCartaTM Panel: exploring therapeutic targets[J]. Ann Oncol, 2015, 26(8): 1748-1753.
4 Vieira T, Duruisseaux M, Ruppert AM, et al. Pulmonary sarcomatoid carcinoma[J]. Bull Cancer, 2012, 99(10): 995-1001.
5 Conor E Steuer, Madhusmita Behera, Yuan Liu, et al. Pulmonary sarcomatoid carcinoma: an analysis of the national cancer data base[J]. Clin Lung Cancer, 2017,18(3): 286-292.
6 Mochizuki T, Ishii G, Nagai K, et al. Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases[J]. Am J Surg Pathol, 2008, 32(11): 1727-1735.
7 Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases[J]. Cancer, 1999, 86(4): 608-616.
8 Martin LW, Correa AM, Ordonez NG, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis[J]. Ann Thorac Surg, 2007, 84(3): 973-980.
9 Vieira T, Girard N, Ung M, et al. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma[J]. J Thorac Oncol, 2013, 8(12): 1574-1577.
10 Steuer CE, Behera M, Liu Y, et al. Pulmonary sarcomatoid carcinoma:an analysis of the national cancer data base[J]. Clin Lung Cancer, 2017, 18(3): 286-292.
11 Shiroyama T, Tanaka A, Tamiya M, et al. A rare case of pleomorphic carcinoma of the lung harboring an anaplastic lymphoma kinase(ALK)rearrangement[J]. Intern Med, 2015, 54: 2741-2743.
12 Murakami Y, Saka H, Oki M. Response to crizotinib and clinical outcome in ALK-rearranged pulmonary pleomorphic carcinoma[J]. J Thorac Oncol, 2015, 10: e28-e29.
13 Maruyama R, Matsumura F, Shibata Y, et al. Detection of ALK rearrangement in an octogenarian patient with pleomorphic carcinoma of the lung[J]. Gen Thorac Cardiovasc Surg, 2016, 64: 167-169.
14 Chen X, Zhang Y, Lu J, Xu C, et al. Pulmonary sarcomatoid carcinoma with ALK rearrangement: frequency, clinical-pathologic characteristics, and response to ALK inhibitor[J].Transl Oncol, 2017, 10(2): 115-120.

备注/Memo

备注/Memo:
通信作者: 白 莉, Email: blpost@126.com
更新日期/Last Update: 2021-06-20